Sotac Pharmaceuticals Limited (NSE:SOTAC)

Sotac Pharmaceuticals Financials Overview

Financials in millions INR. Fiscal year is April - March.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Revenue Revenue Growth	1,016	1,016	1,003	1,040	774.83	731.52
Revenue Growth	19.98%	1.33%	-3.57%	34.18%	5.92%	49.77%
Gross Profit Gross Profit Growth	370.77	370.77	319.45	243.53	202.14	171.75
Operating Income Operating Income Growth	128.27	128.27	131.25	57.2	53.13	68.51
Net Income Net Income Growth	57.67	57.67	80.27	42.81	28.79	28.79
Earnings Per Share EPS Growth	5.22	5.22	7.26	3.90	3.58	3.58
EPS Growth	-32.54%	-28.10%	86.15%	9.04%	0.02%	-

Cash & Debt

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Investments Cash & Investments Growth	11.78	11.78	20.23	38.51	100.94	0.28
Total Debt Total Debt Growth	375.97	375.97	436.99	248.59	220.39	73.88
Net Cash (Debt) Net Cash Growth	-364.19	-364.19	-416.76	-210.08	-119.45	-73.6
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share Net Cash Per Share Growth	-32.97	-32.97	-37.72	-19.14	-14.84	-9.14

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Cash Flow Operating Cash Flow Growth	168.67	168.67	-43.31	-160.76	81.43	63.51
Capital Expenditures CapEx Growth	-78.94	-78.94	-170.16	-177.89	-90	-35.04
Free Cash Flow Free Cash Flow Growth	89.73	89.73	-213.47	-338.65	-8.57	28.46
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Chart

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Gross Margin	36.50%	36.50%	31.86%	23.42%	26.09%	23.48%
Operating Margin	12.63%	12.63%	13.09%	5.50%	6.86%	9.37%
Pretax Margin	8.56%	8.56%	11.09%	3.81%	5.07%	6.42%
Profit Margin	5.68%	5.68%	8.01%	4.12%	3.72%	3.94%
FCF Margin	8.83%	8.83%	-21.29%	-32.57%	-1.11%	3.89%

Dividends

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Dividend Per Share Dividend Per Share Growth	0.200	0.200	0.100	-	-	2.000
Dividend Per Share Growth	0%	100.00%	-	-	-	-
Dividend Yield	0.23%	0.18%	0.08%	-	-	-

Valuation

Chart

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Aug 22, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
PE Ratio	17.25	20.93	16.35	31.23	-	-
P/FCF Ratio	11.09	13.45	-	-	-	-
PS Ratio	0.98	1.19	1.31	1.29	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 20, 2026

Data Sources Report a data error